{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:51:44Z","timestamp":1790603504000,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82074348"],"award-info":[{"award-number":["82074348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the innovation and development joint project of Shandong Province Natural Science Foundation","award":["ZR2023LZL009"],"award-info":[{"award-number":["ZR2023LZL009"]}]},{"name":"Jinan clinical medical science and technology innovation plan","award":["202225014"],"award-info":[{"award-number":["202225014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30101-6","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:35:20Z","timestamp":1764570920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Paeoniflorin inhibits angiogenesis in multiple myeloma by decreasing the MEF2A level to downregulate the expression of lncRNA MALAT1 within exosomes"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiaqi","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manya","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"30101_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1182\/blood-2008-10-184226","volume":"114","author":"D Hose","year":"2009","unstructured":"Hose, D. et al. Induction of angiogenesis by normal and malignant plasma cells. Blood 114, 128\u2013143 (2009).","journal-title":"Blood"},{"key":"30101_CR2","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","volume":"25","author":"D Ribatti","year":"2006","unstructured":"Ribatti, D., Nico, B. & Vacca, A. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25, 4257\u20134266 (2006).","journal-title":"Oncogene"},{"key":"30101_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/sj.leu.2404402","volume":"21","author":"D Ribatti","year":"2007","unstructured":"Ribatti, D., Nico, B., Crivellato, E., Roccaro, A. M. & Vacca, A. The history of the angiogenic switch concept. Leukemia 21, 44\u201352 (2007).","journal-title":"Leukemia"},{"key":"30101_CR4","first-page":"2210","volume":"8","author":"SV Rajkumar","year":"2002","unstructured":"Rajkumar, S. V. et al. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin. Cancer Res. 8, 2210\u20132216 (2002).","journal-title":"Clin. Cancer Res."},{"key":"30101_CR5","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064.409k07_3064_3073","volume":"93","author":"A Vacca","year":"1999","unstructured":"Vacca, A. et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93, 3064\u20133073 (1999).","journal-title":"Blood"},{"key":"30101_CR6","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1158\/1078-0432.CCR-07-4071","volume":"14","author":"R Ria","year":"2008","unstructured":"Ria, R. et al. Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma. Clin. Cancer Res. 14, 1678\u20131685. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4071 (2008).","journal-title":"Clin. Cancer Res."},{"key":"30101_CR7","doi-asserted-by":"crossref","unstructured":"Ribatti, D. & Vacca, A. Multiple myeloma bone marrow angiogenesis. In Multiple Myeloma. A New Era of Treatment Strategies (eds. Podar, K. & Anderson, K. C.) 138\u2013148 (Bentham Science, 2012).","DOI":"10.2174\/978160805297411201010138"},{"key":"30101_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2007-10-116590","volume":"112","author":"AML Coluccia","year":"2008","unstructured":"Coluccia, A. M. L. et al. Validation of PDGFR and c-Src tyrosine kinases as tumor\/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib. Blood 112, 1346\u20131356 (2008).","journal-title":"Blood"},{"key":"30101_CR9","doi-asserted-by":"crossref","unstructured":"Miaomiao, S. et al. Cancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma. Sci. Rep. 13 (1), 9671 (2023).","DOI":"10.1038\/s41598-023-36092-6"},{"key":"30101_CR10","doi-asserted-by":"publisher","first-page":"106566","DOI":"10.1016\/j.leukres.2021.106566","volume":"105","author":"X Tian","year":"2021","unstructured":"Tian, X. et al. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment. Leuk. Res. 105, 106566 (2021).","journal-title":"Leuk. Res."},{"issue":"2","key":"30101_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/path.4712","volume":"239","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Multiple myeloma exosomes Establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression. J. Pathol. 239 (2), 162\u2013173 (2016).","journal-title":"J. Pathol."},{"issue":"26","key":"30101_CR12","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1038\/s41388-019-0788-4","volume":"38","author":"B Li","year":"2019","unstructured":"Li, B. et al. piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment. Oncogene 38 (26), 5227\u20135238 (2019).","journal-title":"Oncogene"},{"key":"30101_CR13","doi-asserted-by":"publisher","first-page":"6093216","DOI":"10.1155\/2022\/6093216","volume":"2022","author":"XH Nie","year":"2022","unstructured":"Nie, X. H. et al. Paeoniflorin regulates NEDD4L\/STAT3 pathway to induce ferroptosis in human glioma cells. J. Oncol. 2022, 6093216 (2022).","journal-title":"J. Oncol."},{"issue":"24","key":"30101_CR14","first-page":"5092","volume":"15","author":"TWP Kim","year":"2023","unstructured":"Kim, T. W. P. & Induces, E. R. Stress-Mediated apoptotic cell death by generating Nox4-Derived ROS under radiation. Gastric Cancer Nutrients. 15 (24), 5092 (2023).","journal-title":"Gastric Cancer Nutrients"},{"issue":"10","key":"30101_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/kjm2.12736","volume":"39","author":"Z Su","year":"2023","unstructured":"Su, Z. et al. Paeoniflorin inhibits colorectal cancer cell stemness through the miR-3194-5p\/catenin beta-interacting protein 1 axis. Kaohsiung J. Med. Sci. 39 (10), 1011\u20131021 (2023).","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"24","key":"30101_CR16","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.3390\/nu15245092","volume":"15","author":"TW Kim","year":"2023","unstructured":"Kim, T. W. Paeoniflorin induces ER Stress-Mediated apoptotic cell death by generating Nox4-Derived ROS under radiation in gastric cancer. Nutrients 15 (24), 5092 (2023).","journal-title":"Nutrients"},{"issue":"2","key":"30101_CR17","doi-asserted-by":"publisher","first-page":"e99010014","DOI":"10.14440\/jbm.2024.0003","volume":"11","author":"K Jan","year":"2024","unstructured":"Jan, K., Hassan, N., James, A., Hussain, I. & Rashid, S. M. Exploring molecular targets in cancer: unveiling the anticancer potential of Paeoniflorin through a comprehensive analysis of diverse signaling pathways and recent advances. J. Biol. Methods. 11 (2), e99010014 (2024).","journal-title":"J. Biol. Methods"},{"key":"30101_CR18","doi-asserted-by":"publisher","first-page":"115340","DOI":"10.1016\/j.intimp.2025.115340","volume":"164","author":"W Zhu","year":"2025","unstructured":"Zhu, W. et al. Paeoniflorin alleviates necroptosis in acute kidney injury induced by cisplatin and Lansoprazole through targeting TNFAIP3. Int. Immunopharmacol. 164, 115340 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"30101_CR19","doi-asserted-by":"publisher","first-page":"1032282","DOI":"10.3389\/fphar.2022.1032282","volume":"13","author":"C Cao","year":"2022","unstructured":"Cao, C. et al. Deciphering the action mechanism of Paeoniflorin in suppressing pancreatic cancer: a network Pharmacology study and experimental validation. Front. Pharmacol. 13, 1032282 (2022).","journal-title":"Front. Pharmacol."},{"key":"30101_CR20","doi-asserted-by":"publisher","first-page":"117901","DOI":"10.1016\/j.jep.2024.117901","volume":"326","author":"T Wu","year":"2024","unstructured":"Wu, T. et al. The active components and potential mechanisms of Wuji Wan in the treatment of ethanol-induced gastric ulcer: an integrated metabolomics, network Pharmacology and experimental validation. J. Ethnopharmacol. 326, 117901 (2024).","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"30101_CR21","doi-asserted-by":"publisher","first-page":"e24461","DOI":"10.1016\/j.heliyon.2024.e24461","volume":"10","author":"J Li","year":"2024","unstructured":"Li, J. et al. Paeoniflorin increases the anti-tumor efficacy of Sorafenib in tumor-bearing mice with liver cancer via suppressing the NF-kappab\/PD-l1 axis. Heliyon 10 (2), e24461 (2024).","journal-title":"Heliyon"},{"key":"30101_CR22","doi-asserted-by":"publisher","first-page":"6079305","DOI":"10.1155\/2021\/6079305","volume":"2021","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y. et al. Paeoniflorin effect of Schwann Cell-Derived exosomes ameliorates dorsal root ganglion neurons apoptosis through IRE1alpha pathway. Evid. Based Complement. Alternat Med. 2021, 6079305 (2021).","journal-title":"Evid. Based Complement. Alternat Med."},{"issue":"10","key":"30101_CR23","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.21037\/apm-21-2203","volume":"11","author":"J Hao","year":"2022","unstructured":"Hao, J. et al. Network pharmacology-based prediction of inhibiting leukocyte recruitment and angiogenesis of total glucosides of peony against rheumatoid arthritis. Ann. Palliat. Med. 11 (10), 3085\u20133101 (2022).","journal-title":"Ann. Palliat. Med."},{"key":"30101_CR24","doi-asserted-by":"publisher","first-page":"785345","DOI":"10.3389\/fonc.2022.785345","volume":"12","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Paeoniflorin inhibits EMT and angiogenesis in human glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent autophagic degradation. Front. Oncol. 12, 785345 (2022).","journal-title":"Front. Oncol."},{"issue":"3","key":"30101_CR25","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.3892\/mmr.2016.5498","volume":"14","author":"S Wang","year":"2016","unstructured":"Wang, S. Wenhua Liu.Paeoniflorin inhibits proliferation and promotes apoptosis of multiple myeloma cells via its effects on MicroRNA 29b and matrix metalloproteinase 2. Mol. Med. Rep. 14 (3), 2143\u20132149 (2016).","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"30101_CR26","doi-asserted-by":"publisher","first-page":"e19503","DOI":"10.1016\/j.heliyon.2023.e19503","volume":"9","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization. Heliyon 9 (9), e19503 (2023).","journal-title":"Heliyon"},{"key":"30101_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11914-017-0399-3","volume":"15","author":"M Moschetta","year":"2017","unstructured":"Moschetta, M. et al. Bone marrow stroma and vascular contributions to myeloma bone homing. Curr. Osteoporos. Rep. 15, 499\u2013506 (2017).","journal-title":"Curr. Osteoporos. Rep."},{"key":"30101_CR28","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1038\/leu.2013.76","volume":"27","author":"KA Kocemba","year":"2013","unstructured":"Kocemba, K. A. et al. The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis. Leukemia 27, 1729\u20131737 (2013).","journal-title":"Leukemia"},{"key":"30101_CR29","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.7150\/jca.55553","volume":"12","author":"JY Lee","year":"2021","unstructured":"Lee, J. Y. et al. Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: A biomarker for predicting prognosis. J. Cancer. 12, 2825\u20132834 (2021).","journal-title":"J. Cancer"},{"key":"30101_CR30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/bloodadvances.2016003251","volume":"1","author":"T Umezu","year":"2017","unstructured":"Umezu, T. et al. Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis. Blood Adv. 1, 812\u2013823 (2017).","journal-title":"Blood Adv."},{"issue":"9","key":"30101_CR31","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1002\/jcb.25927","volume":"118","author":"X Li","year":"2017","unstructured":"Li, X. et al. Long Non-Coding RNA MALAT1 promotes Proliferation, Angiogenesis, and immunosuppressive properties of mesenchymal stem cells by inducing VEGF and IDO. J. Cell. Biochem. 118 (9), 2780\u20132791 (2017).","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"30101_CR32","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.4103\/jcrt.JCRT_282_19","volume":"15","author":"X Ou","year":"2019","unstructured":"Ou, X. et al. MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer. J. Cancer Res. Ther. 15 (7), 1597\u20131602 (2019).","journal-title":"J. Cancer Res. Ther."},{"issue":"14","key":"30101_CR33","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.7150\/ijbs.28048","volume":"14","author":"JJ Qiu","year":"2018","unstructured":"Qiu, J. J. et al. Exosomal metastasis associated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer. Int. J. Biol. Sci. 14 (14), 1960\u20131973 (2018).","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"30101_CR34","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1080\/21655979.2021.1920325","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu, H., Chi, Z., Jin, H. & Yang, W. MicroRNA miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma. Bioengineered 12 (1), 1611\u20131626 (2021).","journal-title":"Bioengineered"},{"key":"30101_CR35","doi-asserted-by":"crossref","unstructured":"Yan, H. et al. Hu Y.MALAT1 regulates network of microRNA-15a\/16-VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma.Carcinogenesis 44 (10\u201311), 760\u2013772 (2023).","DOI":"10.1093\/carcin\/bgad053"},{"issue":"7","key":"30101_CR36","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1158\/0008-5472.CAN-14-2931","volume":"75","author":"H Hirata","year":"2015","unstructured":"Hirata, H. et al. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 75 (7), 1322\u20131331 (2015).","journal-title":"Cancer Res."},{"issue":"6","key":"30101_CR37","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-13-1455","volume":"20","author":"Y Fan","year":"2014","unstructured":"Fan, Y. et al. TGF-\u03b2-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin. Cancer Res. 20 (6), 1531\u20131541 (2014).","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"30101_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/cas.13587","volume":"109","author":"S Li","year":"2018","unstructured":"Li, S. et al. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 promotes lung adenocarcinoma by directly interacting with specificity protein 1. Cancer Sci. 109 (5), 1346\u20131356 (2018).","journal-title":"Cancer Sci."},{"issue":"2","key":"30101_CR39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tig.2017.11.005","volume":"34","author":"Q Sun","year":"2018","unstructured":"Sun, Q., Hao, Q. & Prasanth, K. V. Nuclear long noncoding rnas: key regulators of gene expression. Trends Genet. 34 (2), 142\u2013157 (2018b).","journal-title":"Trends Genet."},{"issue":"6","key":"30101_CR40","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1161\/HYPERTENSIONAHA.120.15068","volume":"76","author":"Y Yeo","year":"2020","unstructured":"Yeo, Y. et al. Suh W.FGF12 (Fibroblast growth factor 12) inhibits vascular smooth muscle cell remodeling in pulmonary arterial hypertension. Hypertension 76 (6), 1778\u20131786 (2020).","journal-title":"Hypertension"},{"issue":"3","key":"30101_CR41","first-page":"1155","volume":"46","author":"F Tian","year":"2020","unstructured":"Tian, F., Wang, H., Ma, H., Zhong, Y. & Liao, A. miR-144-3p inhibits the proliferation, migration and angiogenesis of multiple myeloma cells by targeting myocyte enhancer factor 2A.Int. J. Mol. Med. 46 (3), 1155\u20131165 (2020).","journal-title":"J. Mol. Med."},{"issue":"7","key":"30101_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12032-024-02392-8","volume":"41","author":"SIS Al-Hawary","year":"2024","unstructured":"Al-Hawary, S. I. S. et al. Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy. Med. Oncol. 41 (7), 171 (2024).","journal-title":"Med. Oncol."},{"key":"30101_CR43","doi-asserted-by":"publisher","first-page":"705697","DOI":"10.3389\/fcell.2021.705697","volume":"9","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. LncRNA NEAT1 promotes gastric cancer progression through miR-17-5p\/TGF\u03b2R2 axis Up-Regulated angiogenesis. Front. Cell. Dev. Biol. 9, 705697 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"30101_CR44","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1186\/s12885-021-08978-z","volume":"21","author":"LW Macharia","year":"2021","unstructured":"Macharia, L. W. et al. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines. BMC Cancer. 21 (1), 1248 (2021).","journal-title":"BMC Cancer"},{"key":"30101_CR45","first-page":"2175","volume":"10","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Paeoniflorin inhibits angiogenesis in rheumatoid arthritis fibroblast-like synoviocytes and zebrafish embryos via the IL-6\/STAT3 pathway. Drug. Des. Devel. Ther. 10, 2175\u20132183 (2016).","journal-title":"Drug. Des. Devel. Ther."},{"key":"30101_CR46","unstructured":"Liu, Y. C. et al. Paeoniflorin inhibits angiogenesis and alleviates diabetic retinopathy by regulating VEGF\/VEGFR2 signaling pathway. J. Diabetes Res. 2017, 1\u20139 (2017)."},{"issue":"12","key":"30101_CR47","first-page":"10164","volume":"119","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Paeoniflorin inhibits endothelial cell proliferation and angiogenesis by suppressing VEGF receptor 2 signaling. J. Cell. Biochem. 119 (12), 10164\u201310174 (2018).","journal-title":"J. Cell. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30101-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:02:15Z","timestamp":1767708135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30101-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30101"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30101-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4231373\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"7 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental methods were approved by the Ethics Committee of the Affiliated Hospital of Shandong University of Traditional Chinese Medicine (2020 Ethics Review-KY-010, AWE-2019-038) and the Second Affiliated Hospital of Traditional Chinese Medicine (2023 Ethics Review-KY-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have read the manuscript and agreed to publish it and declare that there are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"588"}}